Kingsview Wealth Management’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $88.9M | Buy |
205,076
+153,241
| +296% | +$46.5M | 1.08% | 18 |
|
|
2026
Q1 | $11.1M | Buy |
51,835
+757
| +1% | +$169K | 0.15% | 120 |
|
|
2025
Q4 | $8.74M | Sell |
51,078
-1,838
| -3% | -$286K | 0.13% | 155 |
|
|
2025
Q3 | $7.09M | Sell |
52,916
-982
| -2% | -$104K | 0.11% | 199 |
|
|
2025
Q2 | $5.25M | Sell |
53,898
-1,369
| -2% | -$109K | 0.09% | 233 |
|
|
2025
Q1 | $4.02M | Sell |
55,267
-1,015
| -2% | -$79.9K | 0.08% | 248 |
|
|
2024
Q4 | $4.07M | Buy |
56,282
+2,952
| +6% | +$224K | 0.08% | 236 |
|
|
2024
Q3 | $4.35M | Sell |
53,330
-5,650
| -10% | -$491K | 0.09% | 220 |
|
|
2024
Q2 | $6.28M | Buy |
58,980
+140
| +0.2% | +$13.4K | 0.15% | 152 |
|
|
2024
Q1 | $5.72M | Sell |
58,840
-14,420
| -20% | -$1.27M | 0.14% | 160 |
|
|
2023
Q4 | $5.74M | Sell |
73,260
-32,910
| -31% | -$2.24M | 0.17% | 139 |
|
|
2023
Q3 | $6.65M | Buy |
106,170
+53,480
| +101% | +$3.51M | 0.24% | 98 |
|
|
2023
Q2 | $3.39M | Sell |
52,690
-300
| -0.6% | -$16.9K | 0.13% | 167 |
|
|
2023
Q1 | $2.81M | Buy |
52,990
+5,290
| +11% | +$260K | 0.12% | 186 |
|
|
2022
Q4 | $2M | Sell |
47,700
-2,480
| -5% | -$104K | 0.09% | 237 |
|
|
2022
Q3 | $1.84M | Buy |
50,180
+410
| +0.8% | +$18.3K | 0.09% | 241 |
|
|
2022
Q2 | $2.12M | Buy |
49,770
+5,220
| +12% | +$249K | 0.1% | 215 |
|
|
2022
Q1 | $2.39M | Sell |
44,550
-3,250
| -7% | -$189K | 0.11% | 201 |
|
|
2021
Q4 | $3.44M | Buy |
47,800
+15,520
| +48% | +$973K | 0.14% | 157 |
|
|
2021
Q3 | $1.84M | Buy |
32,280
+300
| +0.9% | +$18.3K | 0.09% | 244 |
|
|
2021
Q2 | $2.02M | Buy |
31,980
+140
| +0.4% | +$8.84K | 0.1% | 220 |
|
|
2021
Q1 | $2.04M | Buy |
31,840
+5,860
| +23% | +$319K | 0.12% | 189 |
|
|
2020
Q4 | $1.23M | Buy |
25,980
+12,000
| +86% | +$505K | 0.09% | 237 |
|
|
2020
Q3 | $464K | Buy |
13,980
+50
| +0.4% | +$1.72K | 0.04% | 376 |
|
|
2020
Q2 | $451K | Buy |
13,930
+290
| +2% | +$7.91K | 0.05% | 350 |
|
|
2020
Q1 | $327K | Buy |
13,640
+180
| +1% | +$5.18K | 0.04% | 338 |
|
|
2019
Q4 | $394K | Sell |
13,460
-100
| -0.7% | -$2.66K | 0.05% | 323 |
|
|
2019
Q3 | $313K | Sell |
13,560
-1,790
| -12% | -$37.6K | 0.05% | 323 |
|
|
2019
Q2 | $288K | Buy |
15,350
+2,750
| +22% | +$52.2K | 0.05% | 328 |
|
|
2019
Q1 | $226K | Buy |
+12,600
| New | +$210K | 0.03% | 406 |
|
|
2017
Q3 | – | Sell |
-1,000
| Closed | -$14K | – | 392 |
|
|
2017
Q2 | $14K | Buy |
+1,000
| New | +$14.7K | 0.01% | 260 |
|
Other funds holding LRCX
Kingsview Wealth Management's LRCX Position: Q2 2026 in Review
Kingsview Wealth Management increased its Lam Research (LRCX) stake by 296% in Q2 2026, buying an estimated $46.5M and bringing the position to 205,076 shares worth $88.9M. The position accounts for 1.08% of the portfolio, ranked #18.
Kingsview Wealth Management first reported a position in LRCX in Q2 2017 and has held it in 31 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Kingsview Wealth Management held 205,076 shares of Lam Research worth $88.9M as of Q2 2026.
- Kingsview Wealth Management bought 153,241 Lam Research shares in Q2 2026, an estimated $46.5M.
- Lam Research made up 1.08% of Kingsview Wealth Management's portfolio in Q2 2026, its #18 holding.
- Kingsview Wealth Management first reported a position in Lam Research in Q2 2017 and has held it in 31 quarters since.
- 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.